On ECHEMI
Home > Drugs > Chronic bronchitis
Chronic bronchitis
Chronic bronchitis is a chronic nonspecific inflammation of the trachea, bronchial mucosa and surrounding tissues. Clinically, the main symptoms are repeated attacks of cough, sputum or wheezing, which last for 3 months each year for more than 2 consecutive years. The early symptoms are mild, often occurring in winter and relieved in spring and summer. In the late stage, due to the aggravation of inflammation, the symptoms may exist all year round. Its pathological characteristics are bronchial gland hyperplasia and increased mucosal secretion. The disease progresses slowly and progressively, often complicated by obstructive emphysema. In severe cases, pulmonary hypertension and even cor pulmonale often occur.
Related Drugs
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:

Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.

Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:

Lanxiha Sanlian Pharmaceutical Co., Ltd.

Ambroxol Hydrochloride Oral Solution
Indication: This product is a mucolytic agent and can be used for expectorant treatment of acute and chronic bronchial or pulmonary diseases accompanied by sticky sputum.
Manufacturer:

Suicheng Pharmaceutical Co., Ltd.

Benproperine phosphate oral solution
Indication: It is suitable for coughs caused by various reasons, especially irritating dry coughs, such as colds, pharyngitis, acute and chronic bronchitis, asthma, chronic obstructive pulmonary disease, smoking, allergies and other reasons.
Manufacturer:

Beijing Jiulong Pharmaceutical Co., Ltd.

Orange Granules
Manufacturer:

Jiangxi Minkang Pharmaceutical Co., Ltd.

Pentotheline Citrate Syrup
Indication: Used for dry cough caused by various reasons.
Manufacturer:

Guangzhou Baiyunshan Xingqun Pharmaceutical Co., Ltd.

Vitex Oil Capsules
Manufacturer:

Jilin Cao Huan Dan Pharmaceutical Co., Ltd.

Kechuanjing Syrup
Manufacturer:

Jiangxi Lushan Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.